tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AZN Stock Latest News

AstraZeneca’s Tozorakimab: A Promising COPD Treatment Under Study
Company AnnouncementsAstraZeneca’s Tozorakimab: A Promising COPD Treatment Under Study
9h ago
AZN
AstraZeneca’s New Trial on Liver Fibrosis: A Potential Game-Changer?
PremiumCompany Announcements
AstraZeneca’s New Trial on Liver Fibrosis: A Potential Game-Changer?
9h ago
AZN
AstraZeneca’s Promising Phase 2 Study on Trastuzumab Deruxtecan for HER2 Tumors
PremiumCompany Announcements
AstraZeneca’s Promising Phase 2 Study on Trastuzumab Deruxtecan for HER2 Tumors
9h ago
AZN
AstraZeneca’s MAGELLAN Study: A New Horizon in NSCLC Treatment
PremiumCompany Announcements
AstraZeneca’s MAGELLAN Study: A New Horizon in NSCLC Treatment
9h ago
AZN
AstraZeneca’s Tezepelumab Study: A Potential Game-Changer for Asthma Treatment
PremiumCompany Announcements
AstraZeneca’s Tezepelumab Study: A Potential Game-Changer for Asthma Treatment
9h ago
AZN
AstraZeneca’s Tezepelumab Study: A Potential Game-Changer in Severe Asthma Treatment
PremiumCompany AnnouncementsAstraZeneca’s Tezepelumab Study: A Potential Game-Changer in Severe Asthma Treatment
9h ago
AZN
PRXL
AstraZeneca’s ARTEMIDE-Lung04 Study: A New Hope for mNSCLC Treatment?
Premium
Company Announcements
AstraZeneca’s ARTEMIDE-Lung04 Study: A New Hope for mNSCLC Treatment?
9h ago
AZN
AstraZeneca and Amgen’s Tezepelumab Study: A Potential Game-Changer for COPD Treatment
Premium
Company Announcements
AstraZeneca and Amgen’s Tezepelumab Study: A Potential Game-Changer for COPD Treatment
9h ago
AZN
AMGN
AstraZeneca Completes Key Study on AZD2389’s Drug Interaction Effects
PremiumCompany Announcements
AstraZeneca Completes Key Study on AZD2389’s Drug Interaction Effects
9h ago
AZN
PRXL
AstraZeneca’s Selumetinib Study: A Potential Game-Changer for NF1 Treatment in China
PremiumCompany Announcements
AstraZeneca’s Selumetinib Study: A Potential Game-Changer for NF1 Treatment in China
9h ago
AZN
AstraZeneca’s HER2-low Breast Cancer Study: Key Insights and Market Impact
PremiumCompany Announcements
AstraZeneca’s HER2-low Breast Cancer Study: Key Insights and Market Impact
9h ago
AZN
AstraZeneca’s Phase I Study of AZD6912: A Potential Game-Changer?
PremiumCompany Announcements
AstraZeneca’s Phase I Study of AZD6912: A Potential Game-Changer?
9h ago
AZN
AstraZeneca’s Phase 3 Trial: A New Hope for Advanced Biliary Tract Cancer Treatment
PremiumCompany AnnouncementsAstraZeneca’s Phase 3 Trial: A New Hope for Advanced Biliary Tract Cancer Treatment
9h ago
AZN
AstraZeneca Completes Study on Diagnostic Consistency for Asthma and COPD
Premium
Company Announcements
AstraZeneca Completes Study on Diagnostic Consistency for Asthma and COPD
9h ago
AZN
AstraZeneca’s Groundbreaking Lung Cancer Screening Study: A Potential Game-Changer for Early Detection
Premium
Company Announcements
AstraZeneca’s Groundbreaking Lung Cancer Screening Study: A Potential Game-Changer for Early Detection
9h ago
AZN
AstraZeneca’s ESPERANZA Study: A New Hope for HER2 IHC3+ Solid Tumors
PremiumCompany Announcements
AstraZeneca’s ESPERANZA Study: A New Hope for HER2 IHC3+ Solid Tumors
9h ago
AZN
AstraZeneca’s Phase III Study on Anifrolumab for Cutaneous Lupus: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca’s Phase III Study on Anifrolumab for Cutaneous Lupus: Key Insights for Investors
9h ago
AZN
PRXL
AstraZeneca’s New Study on Benralizumab: Implications for Asthma Treatment and Market Impact
PremiumCompany Announcements
AstraZeneca’s New Study on Benralizumab: Implications for Asthma Treatment and Market Impact
9h ago
AZN
AstraZeneca’s Phase II NSCLC Study: A New Hope for Unresponsive Patients
PremiumCompany Announcements
AstraZeneca’s Phase II NSCLC Study: A New Hope for Unresponsive Patients
9h ago
AZN
AstraZeneca’s New Obesity Study: Potential Market Game-Changer?
PremiumCompany AnnouncementsAstraZeneca’s New Obesity Study: Potential Market Game-Changer?
9h ago
AZN
AstraZeneca’s Latest Study: Unveiling Camizestrant’s Impact on Drug Interactions
Premium
Company Announcements
AstraZeneca’s Latest Study: Unveiling Camizestrant’s Impact on Drug Interactions
9h ago
AZN
AstraZeneca’s AZD5335 Study: A New Hope in Cancer Treatment?
Premium
Company Announcements
AstraZeneca’s AZD5335 Study: A New Hope in Cancer Treatment?
9h ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >